Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hof

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Journal of the American Academy of Dermatology|March 6, 2021
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'"Angela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Journal of the American Academy of Dermatology|June 3, 2020
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Parkinsonism & Related Disorders|September 5, 2021
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patientsElze R Timmers, Martijn van Faassen, Marenka Smit, et al.
Clinical Drug Investigation|May 23, 2007
Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis : A Randomised, Double-Blind, Placebo-Controlled, Multicentre TrialD M Albrecht, K van Ackern, H-J Bender, et al.
Breast (Edinburgh, Scotland)|February 8, 2012
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unitJ Heil, A Gondos, G Rauch, et al.
Toxicology Letters|December 3, 2014
Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposureR Z Boerleider, J D N Olie, J C H van Eijkeren, et al.
BMJ Open Diabetes Research & Care|May 8, 2020
Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adultsMirthe Muilwijk, Susan M I Goorden, Carlos Celis-Morales, et al.
International Journal of Molecular Sciences|February 26, 2022
The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies?Archibold Mposhi, Lin Liang, Kevin P Mennega, et al.
Mycoses|June 20, 2007
OnychomycosisC Seebacher, J Brasch, D Abeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)M Ruhnke, A Böhme, D Buchheidt, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Journal of the American Academy of Dermatology|March 6, 2021
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'"Angela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Journal of the American Academy of Dermatology|June 3, 2020
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Parkinsonism & Related Disorders|September 5, 2021
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patientsElze R Timmers, Martijn van Faassen, Marenka Smit, et al.
Clinical Drug Investigation|May 23, 2007
Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis : A Randomised, Double-Blind, Placebo-Controlled, Multicentre TrialD M Albrecht, K van Ackern, H-J Bender, et al.
Breast (Edinburgh, Scotland)|February 8, 2012
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unitJ Heil, A Gondos, G Rauch, et al.
Toxicology Letters|December 3, 2014
Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposureR Z Boerleider, J D N Olie, J C H van Eijkeren, et al.
BMJ Open Diabetes Research & Care|May 8, 2020
Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adultsMirthe Muilwijk, Susan M I Goorden, Carlos Celis-Morales, et al.
International Journal of Molecular Sciences|February 26, 2022
The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies?Archibold Mposhi, Lin Liang, Kevin P Mennega, et al.
Mycoses|June 20, 2007
OnychomycosisC Seebacher, J Brasch, D Abeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)M Ruhnke, A Böhme, D Buchheidt, et al.
Pageof 29